Primary Cutaneous Marginal Zone Lymphoma: A Comprehensive Review
DOI:
https://doi.org/10.18061/ad.v3i1.9994Keywords:
oncodermatology, oncology, treatment options, clinical researchAbstract
Primary cutaneous marginal zone lymphoma (PCMZL) represents a subset of primary cutaneous B-cell lymphomas (PCBCL) and an even smaller subset of all cutaneous lymphomas. Due to PCMZL’s indolent nature, the differentiation between PCMZL and other more aggressive PCBCLs can be challenging and result in the delay of diagnosis and treatment. The diagnosis of PCMZL requires clinical evaluation combined with immunohistochemical analysis to differentiate it from other lymphoma and non-lymphoma pathologies. The condition’s wide range of treatment options, including novel therapies, have led to various outcomes for patients diagnosed with PCMZL. This comprehensive review article emphasizes the clinical presentation and the methods of diagnosis, including appropriate pathologic evaluation, differentiating factors from other non-PCMZL conditions, and current treatment options for PCMZL.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Jordyn Puccio, Teja Mallela, Nassim Idouraine, Matthew Gallardo, Catherine Chung, Kirsten Johnson, Brittany Dulmage

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This Author Agreement for Academic Dermatology ("Agreement") is entered into by and between The Ohio State University, on behalf of its University Libraries ("Publisher") and the author ("Author").
For good and valuable consideration, Publisher and Author agree as follows:
1. Author hereby grants to Publisher the right to publish, reproduce, distribute, translate, transmit and display his/her submitted work and an abstract thereof ("Work") in the Academic Dermatology